ANIP
Price
$57.44
Change
+$1.43 (+2.55%)
Updated
Nov 5, 04:51 PM (EDT)
3 days until earnings call
PRPH
Price
$2.08
Change
-$0.11 (-5.02%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

ANIP vs PRPH

Header iconANIP vs PRPH Comparison
Open Charts ANIP vs PRPHBanner chart's image
ANI Pharmaceuticals
Price$57.44
Change+$1.43 (+2.55%)
Volume$800
CapitalizationN/A
ProPhase Labs
Price$2.08
Change-$0.11 (-5.02%)
Volume$8.08K
CapitalizationN/A
View a ticker or compare two or three
ANIP vs PRPH Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ANIP vs. PRPH commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Buy and PRPH is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ANIP: $56.02 vs. PRPH: $2.19)
Brand notoriety: ANIP and PRPH are both not notable
ANIP represents the Pharmaceuticals: Other, while PRPH is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANIP: 237% vs. PRPH: 146%
Market capitalization -- ANIP: $1.43B vs. PRPH: $116.75M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. PRPH’s [@Medical Specialties] market capitalization is $116.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.42B. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whilePRPH’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • PRPH’s FA Score: 1 green, 4 red.
According to our system of comparison, PRPH is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while PRPH’s TA Score has 4 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 5 bearish.
  • PRPH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PRPH is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а -3.36% price change this week, while PRPH (@Medical Specialties) price change was -8.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +0.77%, and the average quarterly price growth was -2.42%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.55%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was -1.49%.

Reported Earning Dates

ANIP is expected to report earnings on Feb 27, 2025.

PRPH is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than PRPH($117M). ANIP has higher P/E ratio than PRPH: ANIP (79.85) vs PRPH (17.01). ANIP YTD gains are higher at: 1.596 vs. PRPH (-51.549). ANIP has higher annual earnings (EBITDA): 107M vs. PRPH (-9.64M). ANIP has more cash in the bank: 221M vs. PRPH (3.27M). PRPH has less debt than ANIP: PRPH (18.9M) vs ANIP (286M). ANIP has higher revenues than PRPH: ANIP (487M) vs PRPH (62.7M).
ANIPPRPHANIP / PRPH
Capitalization1.43B117M1,222%
EBITDA107M-9.64M-1,110%
Gain YTD1.596-51.549-3%
P/E Ratio79.8517.01470%
Revenue487M62.7M777%
Total Cash221M3.27M6,765%
Total Debt286M18.9M1,513%
FUNDAMENTALS RATINGS
ANIP vs PRPH: Fundamental Ratings
ANIP
PRPH
OUTLOOK RATING
1..100
717
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
8097
PRICE GROWTH RATING
1..100
6091
P/E GROWTH RATING
1..100
9519
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRPH's Valuation (77) in the Household Or Personal Care industry is in the same range as ANIP (96) in the Pharmaceuticals Other industry. This means that PRPH’s stock grew similarly to ANIP’s over the last 12 months.

PRPH's Profit vs Risk Rating (91) in the Household Or Personal Care industry is in the same range as ANIP (100) in the Pharmaceuticals Other industry. This means that PRPH’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as PRPH (97) in the Household Or Personal Care industry. This means that ANIP’s stock grew similarly to PRPH’s over the last 12 months.

ANIP's Price Growth Rating (60) in the Pharmaceuticals Other industry is in the same range as PRPH (91) in the Household Or Personal Care industry. This means that ANIP’s stock grew similarly to PRPH’s over the last 12 months.

PRPH's P/E Growth Rating (19) in the Household Or Personal Care industry is significantly better than the same rating for ANIP (95) in the Pharmaceuticals Other industry. This means that PRPH’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPPRPH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
71%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEQIX8.000.05
+0.63%
Oaktree Emerging Markets Equity I
PURGX20.460.12
+0.59%
PGIM Global Real Estate R4
MCBVX32.12N/A
N/A
MFS Mid Cap Value B
PFPGX25.88-0.03
-0.12%
Parnassus Growth Equity Institutional
CDVZX17.41-0.03
-0.17%
Columbia Large Cap Value Inst

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-3.73%
DRRX - ANIP
38%
Loosely correlated
-0.75%
SNDL - ANIP
31%
Poorly correlated
+2.37%
PRPH - ANIP
29%
Poorly correlated
+2.34%
ORGO - ANIP
29%
Poorly correlated
+7.19%
AMRX - ANIP
26%
Poorly correlated
-1.06%
More

PRPH and

Correlation & Price change

A.I.dvisor tells us that PRPH and ANIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
+2.34%
ANIP - PRPH
28%
Poorly correlated
-3.73%
RXST - PRPH
23%
Poorly correlated
+0.29%
LFCR - PRPH
21%
Poorly correlated
+1.79%
ATRC - PRPH
21%
Poorly correlated
+0.46%
ASRT - PRPH
21%
Poorly correlated
+2.91%
More